1.1.1.101 acylglycerone-phosphate reductase adipose tissue - 285684 1.1.1.105 all-trans-retinol dehydrogenase (NAD+) adipose tissue - -, 761505 1.1.1.145 3beta-hydroxy-DELTA5-steroid dehydrogenase adipose tissue - 389395, 669061 1.1.1.146 11beta-hydroxysteroid dehydrogenase adipose tissue - 669504, 700178, 711383, 711387, 711752, 711800, 740146, 740803, 740806, 740917, 760680, 760682, 760868 1.1.1.146 11beta-hydroxysteroid dehydrogenase adipose tissue 11beta-hydroxysteroid dehydrogenase mRNA level together with the markers of late adipocyte differentiation are significantly lower in orbital adipose tissue than in subcutaneous tissue. In primary cultures of orbital preadipocytes, there is predominant 11beta-hydroxysteroid dehydrogenase 1 oxoreductase activity with minimal dehydrogenase activity. Orbital adipocytes are smaller, less differentiated and express low levels of 11beta-hydroxysteroid dehydrogenase, but abundant glucocorticoid receptor compared with subcutaneous omental depots 693379 1.1.1.146 11beta-hydroxysteroid dehydrogenase adipose tissue expression of isozyme 11beta-HSD1, in situ hybridization, overview 670065 1.1.1.146 11beta-hydroxysteroid dehydrogenase adipose tissue in morbidly obese patients, 11beta-hydroxysteroid dehydrogenase 1 mRNA levlels are higher in subcutaneous adipose tissue than in visceral adipose tissue. Subcutaneous adipose tissue 11beta-hydroxysteroid dehydrogenase 1 levels increase parallel according to body mass index category. No correlation between subcutaneous adipose tissue or visceral adipose tissue with fasting glucose, total cholesterol, triglycerides, and high-density lipoprotein 694486 1.1.1.146 11beta-hydroxysteroid dehydrogenase adipose tissue isoform 11beta-HSD1 is highly expressed in freshly isolated omental adipose stromal vascular cells, predominantly in preadipocytes. The enzxyme acts as an 11beta-reduxtase, reactivating glucocorticoids. Glucocorticoid reactivation is higher in intact mesenteric cells than in thigh and axillary depots 686414 1.1.1.146 11beta-hydroxysteroid dehydrogenase adipose tissue sucrose can promote increased 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase message in mesenteric fat while concomitantly decreasing 11beta-dehydroxysteroid dehydrogenase message and increasing hexose-6-phosphate dehydrogenase message in liver 693785 1.1.1.146 11beta-hydroxysteroid dehydrogenase adipose tissue the activity of 11beta-HSD1 is increased in adipose tissue of obese Zucker rats 695409 1.1.1.149 20alpha-hydroxysteroid dehydrogenase adipose tissue abdominal subcutaneous and omental adipose tissue, the enzyme activity is highest in women with visceral obesity, expression analysis 669621 1.1.1.184 carbonyl reductase (NADPH) adipose tissue - 762424 1.1.1.213 3alpha-hydroxysteroid 3-dehydrogenase (Re-specific) adipose tissue the enzyme expression is positively correlated to adiposity in woman 668392 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) adipose tissue subcutaneous, high expression level 722328 1.1.1.36 acetoacetyl-CoA reductase adipose tissue - 286615 1.1.1.36 acetoacetyl-CoA reductase adipose tissue isozymes AKR1B15.1 and AKR1B15.2 740743 1.1.1.40 malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) adipose tissue - 739138 1.1.1.42 isocitrate dehydrogenase (NADP+) adipose tissue - 656247 1.1.1.43 phosphogluconate 2-dehydrogenase adipose tissue a 6PGD gene expression pattern in ovines differing in weight is not followed by analogous changes of its enzymatic activity suggesting that other post transcription or post translation regulation is involved 710864 1.1.1.44 phosphogluconate dehydrogenase (NADP+-dependent, decarboxylating) adipose tissue - 286826, 668323 1.1.1.44 phosphogluconate dehydrogenase (NADP+-dependent, decarboxylating) adipose tissue a 6PGD gene expression pattern in ovines differing in weight is not followed by analogous changes of its enzymatic activity suggesting that other post transcription or post translation regulation is involved 710864 1.1.1.47 glucose 1-dehydrogenase [NAD(P)+] adipose tissue - 711346 1.1.1.51 3(or 17)beta-hydroxysteroid dehydrogenase adipose tissue male abdominal, 17beta-HSD type 2 is localized in the vasculature of the adipose compartment, real-time RT-PCR expression analysis 741000 1.1.1.62 17beta-estradiol 17-dehydrogenase adipose tissue isozymes AKR1B15.1 and AKR1B15.2 740743 1.1.1.62 17beta-estradiol 17-dehydrogenase adipose tissue retroperitonea, high mRNA expression 688007 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) adipose tissue - 287360, 698813 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) adipose tissue higher expression level 712993 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) adipose tissue highest activity observed 657144 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) adipose tissue renal-adipose tissue 287335 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (NAD+) adipose tissue - 700178 1.1.1.B40 11beta-hydroxysteroid dehydrogenase (NAD+) adipose tissue high-fat fed animals overexpress 11beta-hydroxysteroid dehydrogenase type 2 in subcutaneous but not in retroperitoneal fat. Enzyme mRNA levels strongly correlate in both tissues with different parameters related to obesity, such as body weight, adiposity, and insulin resistance 693880 1.13.11.20 cysteine dioxygenase adipose tissue - 693792, 695529 1.13.11.31 arachidonate 12-lipoxygenase adipose tissue visceral adipose tissue. 12/15-LO is upregulated in white adipose tissue in the obese state 743718 1.13.11.31 arachidonate 12-lipoxygenase adipose tissue visceral, gene ALOX12 expression positively correlated with expression of inflammatory genes encoding IL-6, IL-12a, CXCL10, and lipocalin-2 742976 1.13.11.33 arachidonate 15-lipoxygenase adipose tissue - 742239 1.13.11.33 arachidonate 15-lipoxygenase adipose tissue visceral adipose tissue 743718 1.13.11.34 arachidonate 5-lipoxygenase adipose tissue - 684399 1.13.11.63 beta-carotene 15,15'-dioxygenase adipose tissue - 713952, 714616, 744160 1.13.11.71 carotenoid-9',10'-cleaving dioxygenase adipose tissue - 728552, 744160 1.14.11.2 procollagen-proline 4-dioxygenase adipose tissue increase in expression with growth stage, higher expression in muscle than in adipose tissue 684797 1.14.11.65 [histone H3]-dimethyl-L-lysine9 demethylase adipose tissue - 754880 1.14.19.1 stearoyl-CoA 9-desaturase adipose tissue - 673510, 687321, 687766, 696445, 701423, 716200, 746542 1.14.19.1 stearoyl-CoA 9-desaturase adipose tissue a reduced protein diet does not change protein expression and activity in subcutaneous adipose tissue 672831 1.14.19.1 stearoyl-CoA 9-desaturase adipose tissue Angus and Wagyu steers consuming high-roughage diets exhibit large differences in adipose tissue fatty acid composition, but there are no differences in terminal measures of SCD activity or gene expression 674215 1.14.19.1 stearoyl-CoA 9-desaturase adipose tissue high expression level of isozyme SCD1 688769 1.14.19.1 stearoyl-CoA 9-desaturase adipose tissue hSCD1, sevenfold higher mRNA level in adipose tissue than in liver, real-time PCR 671701 1.14.19.1 stearoyl-CoA 9-desaturase adipose tissue injection of Scd1 sequence-specific antisense oligodeoxynucleotides decreases Scd1 gene expression in brown and white adipose tissue as well as in liver 675062 1.14.19.1 stearoyl-CoA 9-desaturase adipose tissue interfascicular and subcutaneous 674213 1.14.19.1 stearoyl-CoA 9-desaturase adipose tissue low expression level of isozyme SCD1 688769 1.14.19.1 stearoyl-CoA 9-desaturase adipose tissue mRNA levels increases after 8 mg/day rosiglitazone treatment 673260 1.14.19.1 stearoyl-CoA 9-desaturase adipose tissue SCD1 -, 673507 1.14.19.1 stearoyl-CoA 9-desaturase adipose tissue SCD1 isoform 673285 1.14.19.1 stearoyl-CoA 9-desaturase adipose tissue subcutaneous, gene expression very low in tissue from the short-fed steers fed the corn-based diet 674215 1.14.19.17 sphingolipid 4-desaturase adipose tissue - 744398 1.14.19.3 acyl-CoA 6-desaturase adipose tissue expression is higher in salmon fed a diet containing vegetable oil than in fish fed a diet containing fish oil 659836 1.14.19.3 acyl-CoA 6-desaturase adipose tissue subcutaneous adipose tissue and visceral adipose tissue 745516 1.14.19.30 acyl-lipid (8-3)-desaturase adipose tissue - 746201 1.14.19.47 acyl-lipid (9-3)-desaturase adipose tissue highest DELTA6fad mRNA expression is detected in liver followed by brain, with lower expression in other tissues including intestine, eye, muscle, adipose, heart kidney and gill, and lowest expression in stomach and spleen 746261 1.2.1.25 branched-chain alpha-keto acid dehydrogenase system adipose tissue - 762713 1.2.1.25 branched-chain alpha-keto acid dehydrogenase system adipose tissue subcutaneous 762596 1.2.1.36 retinal dehydrogenase adipose tissue - -, 743142 1.2.3.1 aldehyde oxidase adipose tissue isoform AOX1 mRNA is higher in visceral compared to subcutaneous adipose tissue, Aox1 protein is detected in both fat depots 697933 1.2.4.4 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) adipose tissue - 675563 1.3.3.6 acyl-CoA oxidase adipose tissue - 391072, 657145 1.3.99.23 all-trans-retinol 13,14-reductase adipose tissue - -, 700301, 763507, 763769 1.4.3.21 primary-amine oxidase adipose tissue - 686052, 686264 1.4.3.21 primary-amine oxidase adipose tissue most of the SSAO found in adipose tissue originates from mature adipocytes 688255 1.4.3.21 primary-amine oxidase adipose tissue SSAO activity is present in white adipose tissues of wild type but is absent in AOC3KO mice 688487 1.4.3.21 primary-amine oxidase adipose tissue SSAO activity regulates NO availability in white adipose tissue 687077 1.4.3.4 monoamine oxidase adipose tissue in human subcutaneous adipose tissue, the adipocyte-enriched fraction exhibits seven-fold higher amine oxidase activity and contains 3- to 7-fold higher levels of mRNAs encoded by MAO-A and MAO-B genes than the stroma-vascular fraction. MAO-A gene accounts for the majority of the respective MAO and SSAO activities in human adipose tissue. Most of the SSAO and MAO found in adipose tissue originated from mature adipocytes 685418 1.4.3.4 monoamine oxidase adipose tissue most of the monoamine oxidase found in adipose tissue originates from mature adipocytes 688255 1.5.1.5 methylenetetrahydrofolate dehydrogenase (NADP+) adipose tissue - 742856 1.6.3.5 renalase adipose tissue - 742004 1.8.1.10 CoA-glutathione reductase adipose tissue - 395105 1.8.4.2 protein-disulfide reductase (glutathione) adipose tissue - 394810, 394812, 394817 2.1.1.1 nicotinamide N-methyltransferase adipose tissue - 701990, 706094 2.1.1.1 nicotinamide N-methyltransferase adipose tissue expression analysis, overview 701990 2.1.1.221 tRNA (guanine9-N1)-methyltransferase adipose tissue - 737064 2.1.1.72 site-specific DNA-methyltransferase (adenine-specific) adipose tissue - 719373 2.3.1.135 phosphatidylcholine-retinol O-acyltransferase adipose tissue - -, 674449, 674487 2.3.1.15 glycerol-3-phosphate 1-O-acyltransferase adipose tissue - 676839, 757868 2.3.1.15 glycerol-3-phosphate 1-O-acyltransferase adipose tissue brown and white, high expression level 757868 2.3.1.15 glycerol-3-phosphate 1-O-acyltransferase adipose tissue expression detected by RT-PCR 701448 2.3.1.15 glycerol-3-phosphate 1-O-acyltransferase adipose tissue high expression level 757165 2.3.1.15 glycerol-3-phosphate 1-O-acyltransferase adipose tissue highest expression in white adipose tissue, moderate in brown adipose tissue 701623 2.3.1.15 glycerol-3-phosphate 1-O-acyltransferase adipose tissue moderate expression 701623 2.3.1.20 diacylglycerol O-acyltransferase adipose tissue - -, 486489, 659670, 706006 2.3.1.20 diacylglycerol O-acyltransferase adipose tissue increase of enzyme expression in diabetic animals 657753 2.3.1.20 diacylglycerol O-acyltransferase adipose tissue isoform DGAT1 659853 2.3.1.21 carnitine O-palmitoyltransferase adipose tissue - 657826, 703294, 735980 2.3.1.21 carnitine O-palmitoyltransferase adipose tissue CPT1-B 659899 2.3.1.22 2-acylglycerol O-acyltransferase adipose tissue - 486597, 486609, 659670, 701625 2.3.1.22 2-acylglycerol O-acyltransferase adipose tissue MGAT1 701625 2.3.1.23 1-acylglycerophosphocholine O-acyltransferase adipose tissue low content 755989 2.3.1.26 sterol O-acyltransferase adipose tissue - 486683 2.3.1.26 sterol O-acyltransferase adipose tissue ACAT1 enzyme, high mRNA signal 486706 2.3.1.26 sterol O-acyltransferase adipose tissue ACAT1 expression is significantly increased in the adipose tissue of ob/ob mice 757226 2.3.1.26 sterol O-acyltransferase adipose tissue low expression 486698 2.3.1.48 histone acetyltransferase adipose tissue - 688978 2.3.1.51 1-acylglycerol-3-phosphate O-acyltransferase adipose tissue - 719977, 720178, 735599 2.3.1.51 1-acylglycerol-3-phosphate O-acyltransferase adipose tissue expressed in 688005 2.3.1.51 1-acylglycerol-3-phosphate O-acyltransferase adipose tissue high expression level of AGPAT10/GPAT3 and AGPAT6/GPAT4 705206 2.3.1.51 1-acylglycerol-3-phosphate O-acyltransferase adipose tissue low expression level -, 705005 2.3.1.75 long-chain-alcohol O-fatty-acyltransferase adipose tissue - 659670 2.3.1.76 retinol O-fatty-acyltransferase adipose tissue - 659670 2.3.1.85 fatty-acid synthase system adipose tissue - 487574 2.3.1.85 fatty-acid synthase system adipose tissue brown adipose tissue -, 487597 2.3.1.85 fatty-acid synthase system adipose tissue epididymal fat pads -, 487570 2.3.1.B41 protein-long-chain fatty-acyl-lysine deacylase (NAD+) adipose tissue - 755904, 755918 2.3.1.B43 protein-lysine desuccinylase (NAD+) adipose tissue - -, 755970, 756563 2.3.3.8 ATP citrate synthase adipose tissue - 488192, 488193, 488197 2.3.3.8 ATP citrate synthase adipose tissue low activity 488192, 488193 2.3.3.8 ATP citrate synthase adipose tissue strong expression 757804 2.4.1.11 glycogen(starch) synthase adipose tissue - 659340, 671257 2.4.1.11 glycogen(starch) synthase adipose tissue expression of Gys-2 is significantly reduced in adipose tissue of peroxisome proliferator-activated receptor alpha-/-, peroxisome proliferator-activated receptor beta/delta-/- and peroxisome proliferator-activated receptor gamma+/- mice 686019 2.4.1.11 glycogen(starch) synthase adipose tissue subcutaneous, expression of GYS2 -, 720446 2.4.1.11 glycogen(starch) synthase adipose tissue subcutaneous, GYS1 720446 2.4.1.17 glucuronosyltransferase adipose tissue expression level is 91% of the expression level in liver 694264 2.4.1.17 glucuronosyltransferase adipose tissue main expression in small intestine, colon, and adipose tissue 703419 2.4.1.186 glycogenin glucosyltransferase adipose tissue - 736558 2.4.1.186 glycogenin glucosyltransferase adipose tissue from breast tissue 735712 2.4.1.313 protein O-mannose beta-1,3-N-acetylgalactosaminyltransferase adipose tissue - 725358 2.4.1.92 (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase adipose tissue - 685784 2.5.1.18 glutathione transferase adipose tissue - -, 721422 2.5.1.6 methionine adenosyltransferase adipose tissue both subcutaneous fat content and intramusclular fat content are higher in obese than in lean pigs. MAT2beta mRNA abundance is lower in both subcutaneous adipose tissue and skeletal muscle in obese pigs compared with lean pigs 705635 2.5.1.6 methionine adenosyltransferase adipose tissue regulatory subunit MAT2beta is expressed at a higher level in liver and duodenum, followed by the stomach, fat and longissinus dorsi muscle 705635 2.7.1.1 hexokinase adipose tissue type I isozyme, type II isozyme 662531 2.7.1.105 6-phosphofructo-2-kinase adipose tissue equal amounts of isozyme L and M 640342 2.7.1.11 6-phosphofructokinase adipose tissue - 640421 2.7.1.137 phosphatidylinositol 3-kinase adipose tissue - 707910 2.7.1.30 glycerol kinase adipose tissue - 641287, 641299 2.7.1.30 glycerol kinase adipose tissue white and brown 641287 2.7.1.40 pyruvate kinase adipose tissue - 641572 2.7.1.48 uridine/cytidine kinase adipose tissue 36% of liver activity 641653 2.7.1.74 deoxycytidine kinase adipose tissue - 706844 2.7.11.1 non-specific serine/threonine protein kinase adipose tissue - 742242 2.7.11.1 non-specific serine/threonine protein kinase adipose tissue very low expression level of WNK1 661007 2.7.11.13 protein kinase C adipose tissue - 676029 2.7.11.17 Ca2+/calmodulin-dependent protein kinase adipose tissue very low level 491278 2.7.11.19 phosphorylase kinase adipose tissue - 676038 2.7.11.2 [pyruvate dehydrogenase (acetyl-transferring)] kinase adipose tissue mainly isozyme PDK2 673007 2.7.11.27 [acetyl-CoA carboxylase] kinase adipose tissue - 640772, 640775, 661526 2.7.11.31 [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase adipose tissue - -, 644967, 692267, 760910 2.7.11.31 [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase adipose tissue visceral adipose tissue, the predominant AMPK subunit in adipose tissue is AMPKalpha1 692267 2.7.11.31 [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase adipose tissue visceral and epididymal 691165 2.7.4.3 adenylate kinase adipose tissue - 721943 2.7.6.1 ribose-phosphate diphosphokinase adipose tissue isoenzymes PRSI and PRSII 642731 2.7.7.14 ethanolamine-phosphate cytidylyltransferase adipose tissue - 693508 2.7.7.9 UTP-glucose-1-phosphate uridylyltransferase adipose tissue - 643748 2.8.2.15 steroid sulfotransferase adipose tissue SULT2A1 675477 2.8.2.2 alcohol sulfotransferase adipose tissue male white epididymal fat pad, no expression in brown fat 692086 2.8.2.20 protein-tyrosine sulfotransferase adipose tissue - 705836 2.8.2.4 estrone sulfotransferase adipose tissue - 723909, 739055 2.8.2.4 estrone sulfotransferase adipose tissue EST expression is detectable in the subcutaneous adipose tissue in both obese women and men. The expression of EST in the abdominal subcutaneous fat of obese and nonobese female human subjects and in primary adipose-derived stem cells (ASCs) isolated from female subjects is low, but the expression of EST increases with the onset of differentiation. EST is detectable in the subcutaneous adipose tissue in both obese women and men, especially in the abdominal area 760317 3.1.1.1 carboxylesterase adipose tissue epididymal 170993 3.1.1.13 sterol esterase adipose tissue - 133829 3.1.1.23 acylglycerol lipase adipose tissue - -, 680845, 730704, 94263, 94270, 94271 3.1.1.28 acylcarnitine hydrolase adipose tissue - 671825 3.1.1.3 triacylglycerol lipase adipose tissue - 694139, 708339, 709226 3.1.1.3 triacylglycerol lipase adipose tissue ATGL is the predominant TG lipase in adipose tissue 707268 3.1.1.3 triacylglycerol lipase adipose tissue expression of ATGL 680071 3.1.1.3 triacylglycerol lipase adipose tissue high expression level of ATGL 707547 3.1.1.3 triacylglycerol lipase adipose tissue HSL and ATGL 709424 3.1.1.3 triacylglycerol lipase adipose tissue specific expression of ATGL 664719 3.1.1.34 lipoprotein lipase adipose tissue - 650369, 652069, 652173, 677471, 691894, 692187, 716101, 730745, 751424, 751830, 80886, 80889, 80891, 80893, 80895, 80898, 80901, 80907, 80911, 80921 3.1.1.34 lipoprotein lipase adipose tissue decrease of enzyme activity in mesenteric and epididymal white adipose tissue upon chronic stress, accompanied by weight reduction of tissue. Decrease of enzyme activity upon acute stress only in retroperitoneal white adipose tissue 665345 3.1.1.34 lipoprotein lipase adipose tissue fasting for 2 weeks provokes a clear decrease in activity. Insulin administration induces an increase in activity 3 h after the injection 679336 3.1.1.34 lipoprotein lipase adipose tissue highest mRNA levels 651409 3.1.1.34 lipoprotein lipase adipose tissue increase in enzyme activity in presponse to feeding, during 4 h, then decrease to basal levels at 6 h. Fasting produces down-regulation of enzyme activity, concomitant with low levels of plasma insulin. Stimulation of enzyme activity by injection of insulin, especially stimulation of the proportion of enzyme in active conformation at the extracellular level 665033 3.1.1.34 lipoprotein lipase adipose tissue range of enzyme activity differs up to 4fold among mink, mice, chinese hamster, rat and guinea pig 664839 3.1.1.34 lipoprotein lipase adipose tissue significantly reduced LPL activity in parametrial adipose tissue from mice fed with conjugated linoleic acid 652987 3.1.1.34 lipoprotein lipase adipose tissue white adipose tissue 80917 3.1.1.4 phospholipase A2 adipose tissue - 653099 3.1.1.5 lysophospholipase adipose tissue - 693213 3.1.1.67 fatty-acyl-ethyl-ester synthase adipose tissue - 646068 3.1.1.67 fatty-acyl-ethyl-ester synthase adipose tissue low activity 646076 3.1.1.79 hormone-sensitive lipase adipose tissue - -, 133829, 646087, 654152, 654401, 654572, 654765, 654792, 655276, 655309, 655415, 655960, 656393, 656598, 690342, 692007, 703845 3.1.1.79 hormone-sensitive lipase adipose tissue perirenal 654901 3.1.2.11 acetoacetyl-CoA hydrolase adipose tissue - 80977 3.1.2.2 palmitoyl-CoA hydrolase adipose tissue brown and white, weak expression of Acot7 in male mice 679133 3.1.3.11 fructose-bisphosphatase adipose tissue - 170806 3.1.3.16 protein-serine/threonine phosphatase adipose tissue - 134595, 134638 3.1.3.16 protein-serine/threonine phosphatase adipose tissue reduced acitvity in diabetic animals 134651 3.1.3.4 phosphatidate phosphatase adipose tissue - 134861, 134867, 134871, 134882, 751977 3.1.3.4 phosphatidate phosphatase adipose tissue lipin-1 709419 3.1.3.4 phosphatidate phosphatase adipose tissue lipin-1 accounts for all of the PAP1 activity in adipose tissue and skeletal muscle 693521 3.1.3.4 phosphatidate phosphatase adipose tissue PAP1 activity increases during adipogenesis 693153 3.1.3.43 [pyruvate dehydrogenase (acetyl-transferring)]-phosphatase adipose tissue high level of PDP2 649778 3.1.3.43 [pyruvate dehydrogenase (acetyl-transferring)]-phosphatase adipose tissue PDP2 642164 3.1.3.43 [pyruvate dehydrogenase (acetyl-transferring)]-phosphatase adipose tissue PDP2, probably target for insulin activation 642159 3.1.3.46 fructose-2,6-bisphosphate 2-phosphatase adipose tissue - 94935 3.1.3.48 protein-tyrosine-phosphatase adipose tissue - 692092, 694827 3.1.3.5 5'-nucleotidase adipose tissue - 95049, 95057 3.1.3.75 phosphoethanolamine/phosphocholine phosphatase adipose tissue low expression, 3.38fold higher than in liver 680993 3.1.4.1 phosphodiesterase I adipose tissue PC-1 is either overexpressed or overactive in adipose tissue of insulin-resistant individuals both nondiabetic and diabetic 697620 3.1.4.39 alkylglycerophosphoethanolamine phosphodiesterase adipose tissue despite a lower expression, murine autotaxin alpha is detected in brain and adipose tissue 680925 3.1.4.39 alkylglycerophosphoethanolamine phosphodiesterase adipose tissue medium of cultured adipocytes 650814 3.1.4.53 3',5'-cyclic-AMP phosphodiesterase adipose tissue axillae 686518 3.1.6.2 steryl-sulfatase adipose tissue transcription is regulated by two promoters which differ from the prevalent placental one. Specific activity of adipose tissue enzyme is about 50-100 times lower than by placenta enzyme 681104 3.3.2.10 soluble epoxide hydrolase adipose tissue - 731877 3.3.2.9 microsomal epoxide hydrolase adipose tissue - 699759, 732905 3.4.11.3 cystinyl aminopeptidase adipose tissue - -, 710071, 754109 3.4.11.4 tripeptide aminopeptidase adipose tissue - 679509 3.4.11.4 tripeptide aminopeptidase adipose tissue mesenteric and gonadal white adipose tissue and brown adipose tissue 679509 3.4.14.5 dipeptidyl-peptidase IV adipose tissue - 704840 3.4.17.23 angiotensin-converting enzyme 2 adipose tissue - 694170 3.4.17.23 angiotensin-converting enzyme 2 adipose tissue epididymal adipose tissue 710532 3.4.21.42 complement subcomponent C1s adipose tissue - 753047 3.4.21.B28 fibroblast activation protein alpha subunit adipose tissue - 731821 3.4.21.B45 kallikrein 14 adipose tissue - 752891 3.4.22.27 cathepsin S adipose tissue - 697418 3.4.22.27 cathepsin S adipose tissue subcutaneous, of obese and lean individuals, adipocytes and stromal vascular fraction, the enzyme level in obese tissue is increased, genetic profiling and expression analysis, overview 668538 3.4.22.38 cathepsin K adipose tissue - 695943 3.4.22.38 cathepsin K adipose tissue visceral, cathepsin K activity gradually increases in the process of adipocyte differentiation 669625 3.4.22.53 calpain-2 adipose tissue - 643979 3.4.22.B29 calpain 9 adipose tissue - 755220 3.4.22.B71 SENP2 peptidase adipose tissue - 754442 3.4.24.17 stromelysin 1 adipose tissue subcutaneous and gonadal adipose tissue. Significantly reduced MMP-3 expression in MMP-10-deficient adipose tissues 707379 3.4.24.22 stromelysin 2 adipose tissue subcutaneous and gonadal adipose tissue 707379 3.4.24.24 gelatinase A adipose tissue - -, 733414 3.4.24.56 insulysin adipose tissue - 710682 3.4.24.B10 ADAM12 endopeptidase adipose tissue - 668419 3.4.24.B3 matrix metalloproteinase-11 adipose tissue subcutaneous and gonadal adipose tissue 707379 3.5.3.1 arginase adipose tissue tissues grouped based on their expression as follows, from lowest to highest: 1. intestine; 2. adipose tissue, spleen, blood, head kidney, scales and tail fin; 3. adipose fin, brain, heart, gonad, muscle and thymus; 4. skin; 5. gills and liver; 6. posterior kidney 753605 3.5.3.1 arginase adipose tissue tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. intestine and tail fin; 3. adipose tissue, spleen, gills and scales; 4. adipose fin, skin, blood, posterior kidney, gonad, head kidney and thymus; 5. heart; 6. brain and muscle 753605 3.5.3.1 arginase adipose tissue tissues grouped based on their expression as follows, from lowest to highest: 1. liver; 2. tail fin; 3. adipose tissue, intestine, posterior kidney, head kidney, heart and skin; 4. blood, gonad, scales, gills, spleen, brain, thymus; 5. adipose fin and muscle 753605 3.5.3.1 arginase adipose tissue tissues grouped based on their expression as follows, from lowest to highest: 1. tail fin, intestine and scales; 2. adipose tissue, spleen and head kidney; 3. adipose fin and posterior kidney; 4. blood, muscle and thymus; 5. gills; 6. brain, skin, heart, gonad and liver 753605 3.5.99.6 glucosamine-6-phosphate deaminase adipose tissue subcutaneous fat and abdominal fat, high expression level 757909 3.6.1.45 UDP-sugar diphosphatase adipose tissue - 711078 3.6.1.5 apyrase adipose tissue - 733060 4.1.1.32 phosphoenolpyruvate carboxykinase (GTP) adipose tissue - 667839, 679083, 693990 4.1.1.90 peptidyl-glutamate 4-carboxylase adipose tissue expression of rat vitamin K-dependent carboxylase in adult and embryonic tissues 697786 4.2.1.11 phosphopyruvate hydratase adipose tissue enolase I 33604 4.4.1.5 lactoylglutathione lyase adipose tissue - 37413 5.2.1.8 peptidylprolyl isomerase adipose tissue - 715609 5.3.3.12 L-dopachrome isomerase adipose tissue - 748280 5.3.4.1 protein disulfide-isomerase adipose tissue - 703301 6.1.1.12 aspartate-tRNA ligase adipose tissue - 744436 6.1.1.21 histidine-tRNA ligase adipose tissue - 745301 6.2.1.1 acetate-CoA ligase adipose tissue - 563, 572 6.2.1.16 acetoacetate-CoA ligase adipose tissue - 648, 673444 6.2.1.16 acetoacetate-CoA ligase adipose tissue expression is particularly abundant in white adipose tissue 702149 6.2.1.2 medium-chain acyl-CoA ligase adipose tissue - 675 6.2.1.24 phytanate-CoA ligase adipose tissue - 702 6.2.1.3 long-chain-fatty-acid-CoA ligase adipose tissue - 671335, 733 6.2.1.3 long-chain-fatty-acid-CoA ligase adipose tissue gonadal and inguinal adipose tissue 675267 6.3.1.2 glutamine synthetase adipose tissue - 693789 6.3.1.2 glutamine synthetase adipose tissue higher to moderate expression level 691904 6.3.4.15 biotin-[biotin carboxyl-carrier protein] ligase adipose tissue - 1444, 1445 6.3.5.2 GMP synthase (glutamine-hydrolysing) adipose tissue - 1354 6.4.1.1 pyruvate carboxylase adipose tissue - 690828 6.4.1.1 pyruvate carboxylase adipose tissue high activity 649667 6.4.1.2 acetyl-CoA carboxylase adipose tissue - 37593, 37628, 664193, 666733, 671950, 675028, 694384, 702619 6.4.1.2 acetyl-CoA carboxylase adipose tissue epididymal 37593 6.4.1.2 acetyl-CoA carboxylase adipose tissue isozyme Acc1 664193, 664564 6.4.1.2 acetyl-CoA carboxylase adipose tissue white and brown 37606 7.2.2.10 P-type Ca2+ transporter adipose tissue - 718751